Indivior Pharmaceuticals (INDV) Other Working Capital Changes (2024 - 2026)
Indivior Pharmaceuticals has reported Other Working Capital Changes over the past 3 years, most recently at $18.0 million for Q1 2026.
- For Q1 2026, Other Working Capital Changes changed 0.0% year-over-year to $18.0 million; the TTM value through Mar 2026 reached -$49.0 million, down 232.43%, while the annual FY2025 figure was -$49.0 million, 87.0% up from the prior year.
- Other Working Capital Changes for Q1 2026 was $18.0 million at Indivior Pharmaceuticals, up from -$11.0 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $18.0 million in Q1 2025 and troughed at -$396.0 million in Q1 2024.
- A 3-year average of -$45.3 million and a median of $3.0 million in 2024 define the central range for Other Working Capital Changes.
- On a YoY basis, Other Working Capital Changes climbed as much as 104.55% in 2025 and fell as far as 1733.33% in 2025.
- Year by year, Other Working Capital Changes stood at $12.0 million in 2024, then plummeted by 191.67% to -$11.0 million in 2025, then soared by 263.64% to $18.0 million in 2026.
- Business Quant data shows Other Working Capital Changes for INDV at $18.0 million in Q1 2026, -$11.0 million in Q4 2025, and -$7.0 million in Q3 2025.